Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Jones

Showing results (221-230 of 332) with videos related to

Pageof 34
Sort By:
Nature Communications|August 24, 2019
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in gliomaNathan R Fons, Ranjini K Sundaram, Gregory A Breuer, et al.
Acta Neuropathologica|April 13, 2017
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic driversAndrey Korshunov, Daniel Schrimpf, Marina Ryzhova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseBarbara S Paugh, Chunxu Qu, Chris Jones, et al.
Pediatric Hematology and Oncology|April 26, 2021
High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapiesJanice Pearce, Komel Khabra, Henry Nanji, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2019
Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2Márcia Santos Pereira, Sónia Pires Celeiro, Ângela Margarida Costa, et al.
Acta Neuropathologica|March 21, 2020
Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutationDavid Castel, Thomas Kergrohen, Arnault Tauziède-Espariat, et al.
Metabolism: Clinical and Experimental|September 10, 2015
Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome in the context of inherited lipodystrophiesFrederic Reinier, Magdalena Zoledziewska, David Hanna, et al.
Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.
Plos One|April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentDorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.
International Journal of Molecular Sciences|September 18, 2020
Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPGGiulia Pericoli, Stefania Petrini, Ezio Giorda, et al.
Pageof 34

Showing results (221-230 of 332) with videos related to

Sort By:
Pageof 34
Nature Communications|August 24, 2019
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in gliomaNathan R Fons, Ranjini K Sundaram, Gregory A Breuer, et al.
Acta Neuropathologica|April 13, 2017
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic driversAndrey Korshunov, Daniel Schrimpf, Marina Ryzhova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseBarbara S Paugh, Chunxu Qu, Chris Jones, et al.
Pediatric Hematology and Oncology|April 26, 2021
High grade gliomas in young children: The South Thames Neuro-Oncology unit experience and recent advances in molecular biology and targeted therapiesJanice Pearce, Komel Khabra, Henry Nanji, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 9, 2019
Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2Márcia Santos Pereira, Sónia Pires Celeiro, Ângela Margarida Costa, et al.
Acta Neuropathologica|March 21, 2020
Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutationDavid Castel, Thomas Kergrohen, Arnault Tauziède-Espariat, et al.
Metabolism: Clinical and Experimental|September 10, 2015
Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome in the context of inherited lipodystrophiesFrederic Reinier, Magdalena Zoledziewska, David Hanna, et al.
Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.
Plos One|April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentDorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.
International Journal of Molecular Sciences|September 18, 2020
Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPGGiulia Pericoli, Stefania Petrini, Ezio Giorda, et al.
Pageof 34